SEELSEELOS THERAPEUTICS, INC.

Nasdaq seelostherapeutics.com


$ 0.30 $ 0.02 (7.53 %)    

Wednesday, 01-May-2024 15:52:58 EDT
QQQ $ 422.58 $ -3.07 (-0.72 %)
DIA $ 378.81 $ 0.76 (0.2 %)
SPY $ 500.35 $ -1.63 (-0.32 %)
TLT $ 88.50 $ 0.65 (0.74 %)
GLD $ 213.80 $ 1.92 (0.91 %)
$ 0.3
$ 0.29
$ 0.00 x 0
$ 0.00 x 0
$ 0.28 - $ 0.31
$ 0.27 - $ 49.80
324,983
na
1.47M
$ 1.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-06-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-10-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-05-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-04-2022 12-31-2021 10-K
10 11-05-2021 09-30-2021 10-Q
11 08-06-2021 06-30-2021 10-Q
12 04-30-2021 03-31-2021 10-Q
13 03-11-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-07-2020 03-31-2020 10-Q
17 03-17-2020 12-31-2019 10-K
18 11-07-2019 09-30-2019 10-Q
19 08-01-2019 06-30-2019 10-Q
20 05-21-2019 03-31-2019 10-Q
21 03-28-2019 12-31-2018 10-K
22 10-31-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-03-2018 03-31-2018 10-Q
25 03-01-2018 12-31-2017 10-K
26 11-02-2017 09-30-2017 10-Q
27 08-02-2017 06-30-2017 10-Q
28 05-11-2017 03-31-2017 10-Q
29 03-13-2017 12-31-2016 10-K
30 11-08-2016 09-30-2016 10-Q
31 08-04-2016 06-30-2016 10-Q
32 05-09-2016 03-31-2016 10-Q
33 03-09-2016 12-31-2015 10-K
34 11-05-2015 09-30-2015 10-Q
35 08-05-2015 06-30-2015 10-Q
36 05-11-2015 03-31-2015 10-Q
37 03-16-2015 12-31-2014 10-K
38 11-10-2014 09-30-2014 10-Q
39 08-11-2014 06-30-2014 10-Q
40 05-12-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 seelos-therapeutics-announces-strategic-focus-on-mental-health-initiatives-and-provides-an-update-on-current-discussions-of-potential-partnerships-and-collaboration-richard-pascoe-appointed-chairman-of-the-board

-Richard Pascoe appointed Chairman of the Board of Directors to spearhead the ongoing business development discussionsNEW YORK,...

 why-lifecore-biomedical-shares-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

 nasdaq-turns-higher-caleres-posts-upbeat-q4-results

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 50 points on Tuesday. The Dow...

 why-peraso-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected four...

 dow-jumps-200-points-core--main-shares-gain-after-q4-results

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 200 points on Tuesday. The Dow traded up...

 nasdaq-down-100-points-us-housing-starts-surge-in-february

U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 100 points on Tuesday. Following the market op...

 cns-disorder-focused-seelos-therapeutics-plunges-to-52-week-low---heres-why

Seelos Therapeutics updates Phase 2/3 HEALEY ALS trial with SLS-005, showing potential efficacy in subgroup analysis. Explore t...

 seelos-therapeutics-provides-update-on-top-line-results-from-its-amyotrophic-lateral-sclerosis-study-with-sls-005

Seelos Therapeutics, Inc. (NASDAQ:SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the developme...

Core News & Articles

https://www.marijuanamoment.net/indiana-lawmakers-send-psilocybin-research-funding-bill-to-governor/   The Indiana legislatur...

Core News & Articles

https://www.marijuanamoment.net/fda-grants-priority-review-of-mdma-assisted-therapy-for-ptsd-psychedelics-drug-development-comp...

 psyched-suggestibility-and-psychedelics-effects-eus-7m-research-fund-australias-treatment-delivery-bz-podcast-and-more

New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedel...

 psychedelics-headlines-anti-inflammatory-effects-global-drug-survey-synthetic-surprise-uks-harm-reduction-hub-and-more

Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and onli...

 seelos-therapeutics-announces-receipt-of-minutes-from-its-end-of-phase-ii-meeting-with-the-us-fda-highlighting-modifications-to-the-primary-and-secondary-endpoints-of-its-phase-ii-study-of-sls-002

Company plans to continue its previously announced potential partnership discussions and expects to proceed to Phase III with S...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION